Insulin resistance: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Anthony.Sebastian
(add pre-note & link)
imported>Anthony.Sebastian
(edit lede)
Line 1: Line 1:
{{subpages}}
{{subpages}}
:See: ''Article on [[insulin]], if necessary, to better understand present article.''
:See: ''Article on [[insulin]], if necessary, to better understand present article.''
---
As described in the 2013 Medical Subject Headings of the National Library of Medicine, '''insulin resistance''' consists of
:<font face="Gill Sans MT">Diminished effectiveness of [[insulin]] in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent [[hyperglycemia]] or [[ketosis]].</font><ref name=meshir>{{MeSH}}</ref>


In [[medicine]], '''insulin resistance''' is "diminished effectiveness of [[insulin]] in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent hyperglycemia or ketosis. Tt can be caused by the presence of insulin antibodies or the abnormalities in insulin receptors (receptor, insulin) on target cell surfaces. It is often associated with [[obesity]]; [[diabetic ketoacidosis]]; [[infection]]; and certain rare conditions."<ref>{{MeSH}}</ref>
It can be caused by the presence of insulin antibodies or the abnormalities in insulin receptors (receptor, insulin) on target cell surfaces. It is often associated with [[obesity]]; [[diabetic ketoacidosis]]; [[infection]]; and certain rare conditions."<ref ref name>=measir/>


[[Insulin resistance]] (HOMA-IR) can be measured by:<ref name="pmid3899825">{{cite journal |author=Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC |title=Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man |journal=Diabetologia |volume=28 |pages=412–9 |year=1985 |pmid=3899825 |doi= |url= |issn=}}</ref>
[[Insulin resistance]] (HOMA-IR) can be measured by:<ref name="pmid3899825">{{cite journal |author=Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC |title=Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man |journal=Diabetologia |volume=28 |pages=412–9 |year=1985 |pmid=3899825 |doi= |url= |issn=}}</ref>

Revision as of 16:58, 21 February 2013

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
See: Article on insulin, if necessary, to better understand present article.

--- As described in the 2013 Medical Subject Headings of the National Library of Medicine, insulin resistance consists of

Diminished effectiveness of insulin in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent hyperglycemia or ketosis.[1]

It can be caused by the presence of insulin antibodies or the abnormalities in insulin receptors (receptor, insulin) on target cell surfaces. It is often associated with obesity; diabetic ketoacidosis; infection; and certain rare conditions."Cite error: Invalid <ref> tag; invalid names, e.g. too many

References